PLA2G7 and coronary artery disorder: Another biomarker of interest is lipoprotein-associated phospholipase A2 (Lp-PLA2), an enzyme produced by inflammatory cells in atherosclerotic plaques that has been associated with the risk of coronary heart disease [15].